Names and pronunciation
(daw-noe-roo′bi-sin) Cerubidine
PDF page 356
Drug reference
(daw-noe-roo′bi-sin) Cerubidine
PDF page 356
Func. class.: Antineoplastic, antibiotic
PDF page 356
Chem. class.: Anthracycline glycoside
PDF page 356
USES: Acute lymphocytic leukemia (ALL), acute myelogenous leukemia (AML)
PDF page 356
CONTRAINDICATIONS: Preg- nancy, breastfeeding, hypersensitivity, systemic infections, cardiac disease, bone marrow depression
PDF page 356
Black Box Warning: IM/SUBCUT use Precautions: Tumor lysis syndrome, MI, infection, thrombocytopenia, renal/ hepatic disease; gout Black Box Warning: Bone marrow sup- pression, cardiac disease, extravasation, renal failure, hepatic disease; requires a specialized care setting and an experi- enced clinician
PDF page 357
DOSAGE AND ROUTES • Adult <60 yr: IV 45 mg/m2/day × 3 days, first cycle, then 2 days second cycle • Adult >−60 yr: IV 30 mg/m2/day × 3 days, then 2 days of subsequent courses in combination, max 400-600 mg/m2 to- tal cumulative dose • Child ≥2 yr: IV 25 mg/m2/day depend- ing on cycle weekly in combination; <2 yr or BSA <0.5 determine on mg/m2/kg basis
PDF page 357
Available forms: Injection 5 mg/mL HIGH ALERT
PDF page 357
• Child ≥2 yr: IV 25 mg/m2/day depend- ing on cycle weekly in combination; <2 yr or BSA <0.5 determine on mg/m2/kg basis
PDF page 357